FDA Notes Theoretical Cancer Risk For Centocor’s Ustekinumab

MAb for psoriasis has favorable odds for a June 17 recommendation by advisory panel, analysts say.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet